NDC 0591-0414

Estropipate

Estropipate

Estropipate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Estropipate.

Product ID0591-0414_fc393e85-ce9e-4647-aac8-77b231b38abf
NDC0591-0414
Product TypeHuman Prescription Drug
Proprietary NameEstropipate
Generic NameEstropipate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1993-09-23
Marketing CategoryANDA / ANDA
Application NumberANDA081213
Labeler NameActavis Pharma, Inc.
Substance NameESTROPIPATE
Active Ingredient Strength1 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0591-0414-01

100 TABLET in 1 BOTTLE, PLASTIC (0591-0414-01)
Marketing Start Date1993-09-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-0414-05 [00591041405]

Estropipate TABLET
Marketing CategoryANDA
Application NumberANDA081213
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1993-09-23

NDC 0591-0414-01 [00591041401]

Estropipate TABLET
Marketing CategoryANDA
Application NumberANDA081213
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-09-23
Marketing End Date2019-10-31

NDC 0591-0414-30 [00591041430]

Estropipate TABLET
Marketing CategoryANDA
Application NumberANDA081213
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1993-09-23

Drug Details

Active Ingredients

IngredientStrength
ESTROPIPATE.75 mg/1

OpenFDA Data

SPL SET ID:4252d631-03d0-4b37-8a0e-c7dc8fc5438a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310213
  • 310212
  • 310215
  • UPC Code
  • 0305910416010
  • 0305910414016
  • 0305910415013
  • NDC Crossover Matching brand name "Estropipate" or generic name "Estropipate"

    NDCBrand NameGeneric Name
    0591-0414EstropipateEstropipate
    0591-0415EstropipateEstropipate
    0591-0416EstropipateEstropipate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.